Biomedical subjects

K Leo

Publications and source records attributed to K Leo.

At least 19 recordsLinked to original sources

PubMed2005

Ultrafast relaxation in quasi-one-dimensional organic molecular crystals.

We present a comprehensive study of ultrafast relaxation properties of optical excitations in thin films of quasi-1D stacked organic materials PTCDA (3,4,9,10-perylenetetracarboxylic dianhydride) and MePTCDI (N,N'-dimethylperylene-3,4,9,10-dicarboximide) over five decades of time. Pump-probe experiments reveal excitonic intraband relaxation time constants of 65 fs for MePTCDI and 100 fs for PTCDA. The initial time-resolved luminescence anisotropy is consistent with the exciton model of Davydov-split states. The subsequent decay of the anisotropy can be explained with a thermally activated exciton hopping process. A full understanding of the pump-probe experiments calls for an explanation beyond the models presently available.

Journal Article↗

PubMed2005

Organic homojunction diodes with a high built-in potential: interpretation of the current-voltage characteristics by a generalized Einstein relation.

We realize p- and n-type doping of the organic semiconductor zinc-phthalocyanine using a novel strong organic donor. This allows us to demonstrate the first stable and reproducible organic p-n homojunctions. The diodes show very high built-in potentials, attractive, e.g., for organic solar cells. However, the diode characteristics cannot be described by the standard Shockley theory of the p-n junction since the ideality factor strongly increases with decreasing temperature. We show that this behavior can be explained by deviations from the Einstein relation for disordered materials.

Journal Article↗

PubMed2001

Coherent external and internal phonons in quasi-one-dimensional organic molecular crystals.

We have directly time resolved coherent phonon oscillations in quasi-one-dimensional organic crystals of MePTCDI ( N-N'-dimethylperylene-3,4,9,10-dicarboximide), using femtosecond pump-probe experiments. We observe both higher-energy oscillations caused by intramolecular vibrations (internal phonons) and, for the first time in a quasi-one-dimensional organic system, lower-energy modulations which are related to coherent lattice phonons (external phonons). For internal A(g) vibrations, the coherence decay time of about 2 ps is almost independent of the mode. In contrast, the damping time of the external phonons increases strongly with decreasing energy.

Journal Article↗

PubMed2001

Field-induced delocalization and Zener breakdown in semiconductor superlattices.

We investigate the energy spectrum and the electron dynamics of a band in a semiconductor superlattice as a function of the electric field. Linear optical spectroscopy shows that, for high fields, the well-known localization of the Bloch states is followed by a field-induced delocalization, associated with Zener breakdown. Using time-resolved measurements, we observe Bloch oscillations in a regime where they are damped by Zener breakdown.

Journal Article↗

PubMed2000

Self-induced shapiro effect in semiconductor superlattices

We observe that the oscillatory motion of photoinjected electron-hole pairs in a biased semiconductor superlattice (Bloch oscillation) is accompanied by a coherent quasi-dc current that is generated by the interaction of the carriers with the self-induced oscillating field. It is shown that this novel macroscopic quantum effect, which is a coherent analog of the Shapiro effect observed in Josephson junctions, can be controlled by changing the spectral position of the exciting laser pulse, which in turn determines the amplitude and phase of the wave packet oscillations. It is thereby possible to coherently drive the electrons either downwards or upwards in the potential of the static field.

Journal Article↗

PubMed1998

Pharmacokinetics and pharmacodynamics of qinghaosu derivatives: how do they impact on the choice of drug and the dosage regimens?

The critical decisions of which artemisinin derivative(s) to use and by which route(s) of administration for falciparum malaria are complex scientifically and politically. Despite the need for additional pharmacokinetic, pharmacodynamic and toxicokinetic data, these drugs are too important to delay concise, rational recommendations any longer. These types of decisions must be made now, implemented on a multinational level with WHO leadership, and revised as new findings emerge. For acute, uncomplicated disease, per os dosing of artesunate or artemether for three days is recommended, but only in combination with other antimalarial drugs like mefloquine. For severe falciparum malaria, intravenous administration is the preferred route, yet current formulations for intravenous dosing are not optimal and should be an area for future development emphasis. Clearly intramuscular administration of artemether has proven effective for severe disease, yet dosing regimens shouldn't be designed with ultimate parasitological cure as the aim and the problem of bioavailability of the sesame oil formulations must be examined further. Once the life-saving reduction in parasitemia and pathophysiological sequelae have been achieved, the patient can be given oral medication to affect radical cure. Much more data will be required to define the role of per rectum dosing for the treatment of severe malaria, yet this approach holds great promise as a life-saving intervention in rural areas where this disease has it most dramatic impact.

Administration, Oral↗

PubMed1996

Total hip and knee replacement treatment programs: a report using consensus.

Physical therapists may use varied treatment protocols for the acute care of patients with to hip or knee replacements. The purpose of this study was to develop, via consensus, a standardized treatment program for patients receiving total hip or knee replacement for primary osteoarthritis. Eighteen clinicians nationwide participated in a three-round consensus process. In Round 1, over 80% of the panel identified exercise, transfers, ambulation, and discharge criteria as the important treatment categories. In Round 2, they reviewed the preliminary physical therapy treatment program and recommended additional exercise regimes. In Round 3, 76% of the panel accepted the final total hip replacement program while 70% of the panel accepted the total knee replacement program. Using the consensus development process, physical therapists may begin to define their treatment programs which is fundamental to establishing a baseline standard of care.

Hip Prosthesis↗

PubMed1995